Gpi Spa · MIL:GPI

Gpi Spa — Investor Presentation (August 2020)

35 slides from Gpi Spa's investor presentation, August 2020

  1. Slide 1: Investor Presentation August 2020

    INVESTOR PRESENTATION AUGUST 2020

  2. Slide 2: The context: Healthcare

    The context Healthcare HEALTHCARE: AN EVOLVING 2019 ITALY HEALTHCARE A PIVOTAL MARKET MARKET EXPENDITURE A segment that can impact a country’s economic • demographic ageing and increased life expectancy 115 B € development, the keeping of • increased health costs public accounts and its very social

  3. Slide 3: Your Global Partner for a Better Future

    > 30 years of experience, management Your Global Partner History of team with a track record of internal Growth growth and M&As for a Better Future International footprint solutions used by more than 2,200 customers in more than 60 countries We develop software, technologies and services to help the

  4. Slide 4: Strategic Business Areas

    Strategic Business Areas TECHNOLOGIES 50.6% Pay 2.8 Automation 4.8 ICT 4.9 Software 38.1 SERVICES 49.4% Care Note: % revenues for SBA out of total revenues referring to FY 2018 4

  5. Slide 5: Supply Lines

    Supply Lines • hospital information system • health social care • blood transfusion & tissue bank Software • health administration main SBAs • data analytics • other 87.5% of total revenue • BPO health care administrative svc. (AtC,..) • telemedicine Care • other • automated pharmacy warehouse Autom

  6. Slide 6: GPI in figures

    GPI in figures A history of steady growth Revenue €M +18.3% Vs 2018 EBITDA €M * • 2013 Orizzonte fund providing equity financing - First minibond issued. • 2016 merger between GPI and the SPAC CFP1. Start of trading in the stock market AIM Italia. 2017 2017 2018 2019 2018 2019 • 2018 graduated from

  7. Slide 7: Gpi vs Covid-19

    Gpi vs Covid-19 • Permanent activity supporting the NHS also during the lockdown • Immediate activation of actions to protect the health of employees, collaborators, suppliers, partners and customers • Reporting a slowdown of the ordinary health care activities and an increase of extraordinary activ

  8. Slide 8: Segmentation

    Segmentation REVENUES by EBITDA by REVENUES by REVENUES by strategic business area strategic business area geographic area customer type* 10% * H-pub: public healthcare customers; H-Pri: private healthcare customers, NH-Pub: public non-healthcare customers; NH-Pri: private non-healthcare customers 8

  9. Slide 9: Focus on SBA software

    Focus on SBA software Tenders win ratio** 35% Adj. revenue €M EBITDA €M Supply lines • Revenue predictivity • 50% Customer retention • 92% Average contract term 30% 35% • 1-3 years 24.2% Average value of tenders acquired 90.3 90.8 24.7% • 6-7 mln/€ year 10% Competitive position 22.3* 21.9 10% 15% •

  10. Slide 10: Focus on SBA Care

    Focus on SBA Care Tenders win ratio** 40% Adj. revenue €M EBITDA €M Supply lines • Revenue predictivity 95% Δ +30% • Customer retention • 97% Average contract term • 4-6 years Average value of tenders acquired 102.5 • 10-15 mln/€ year 6.4% 78.7 4.7% Competitive position 6.6 • 1st operator IT 3.7 * 2

  11. Slide 11: Focus on other SBAs

    Focus on other SBAs Automation Sales of HW for automated warehouses (approx. 87%) 2019 REVENUE Revenue €M EBITDA €M and maintenance and service fees (approx. 13%) • Retail Italy approx. 64% • Hospital Italy approx. 16%; • International Hospital & Retail approx. 20% Δ +21% ICT Desktop management serv

  12. Slide 12: The customers

    The customers +2,200 Public and private customers Hpub Hpri NHpub NHpri 2019 74.5% 2019 9.0% 2019 6.8% 2019 8.8% 2018 74.0% 2018 13.4% 2018 6.3% 2018 6.3% • Healthcare Authorities • Nursing homes, • Municipalities • Large-scale retail channel • Hospitals private clinics, etc. • Provinces • Banks • P

  13. Slide 13: GPI worldwide

    GPI worldwide ITALY > 40 branches SOLUTIONS WORLDWIDE > 60 countries HIS Automation Blood Bank 13

  14. Slide 14: Overview and main results FY2019

    Overview and main results FY2019

  15. Slide 15: Highlights

    Highlights M&As • Haemonetics (assets): U.S. global company listed on the NYSE (Blood Bank) | 11,3 M $ Rev. |35% EBITDA | • Region of Lazio contract start up – 18 lots - and 100 clients USA (May 2020) Regional Contact Centre: • Medinfo Group: 3 companies - France, Tunisia, Chile €72 M in 2 years + 1

  16. Slide 16: Significant growth in 2019

    Significant growth in 2019 Revenues +18.3%, Net profit +3.1% €M 2019 2018 Revenue €240.9 M, +18.3% thanks Revenue and other income 240.9 203.7 to the contribution made by the SBAs: • Care +35.0% Adj. revenue (1) 223.3 192.9 • Other +21.2% • SW +1.2% EBITDA 32.2 28.6 (2) X.X X.X EBITDA % of adj. reve

  17. Slide 17: 2019 financial highlights

    2019 financial highlights A3.1 CERVED Rating confirmed €M 2019 2018 A- S&P |A3 Moody’s | A-1 Fitch Net working capital Net working capital 91.3 75.6 €91.3 M (€75.6 M in 2018): • increase due to growth in revenues and the acquisition of Non-current assets 119.4 (1) 105.2 significant orders at year en

  18. Slide 18: Target market and competitive environment

    Target market and competitive environment

  19. Slide 19: Market Analysis Software

    Market Analysis Software Market value $60 bn value of the global 2018 Healthcare IT software + services market 47 % North America CAGR 18 – 22: 6.1% 28 % Western Europe CAGR 18 – 22: 5.4% 10% Mature Asia/Pacific CAGR 18 – 22: 4.3% 5 % Latin America CAGR 18 – 22: 5.3% 4 % Greater China CAGR 18 – 22:

  20. Slide 20: Market Analysis Software: Top market players

    Market Analysis Software Top market players Focus on Company Brief description Ranking healthcare ICT solutions and related services for public and private healthcare providers.  1st ICT solutions for the segments: Through 5 top players finance, industry, telco&utilities dedicated and PA. healthcar

  21. Slide 21: Market Analysis Care

    Market Analysis Care Market value & players N/A > 28 M citizens reached global market value of administrative services not Company Brief description Ranking available because of its ICT solutions, administrative and 1st heterogeneous nature - social-healthcare services for public and private healthc

  22. Slide 22: Strategic intentions 2020-2024

    Strategic intentions 2020-2024

  23. Slide 23: Strategic-corporate intentions 2020 - 2024

    Strategic-corporate intentions 2020 - 2024 01 02 03 04 05 EVER MORE GROWTH IN ITALY from from GLOBAL PRIVATE HEALTH CARE PRODUCTS/ PROVIDER to HEALTH SW MARKET SERVICES to PARTNER CARE LEADERSHIP INTEGRATED SOLUTIONS Strong increase doubling up of Major regional Greater integration of Multi-business

  24. Slide 24: Strategic intentions SBA Software

    Strategic intentions SBA Software 01. MARKET POSITIONING consolidation of the market position (up-selling and cross-selling), continuous participation in major tenders and DEVELOPMENT DRIVERS strategic partnerships. • Average retention (’17-’19) 91% 02. GLOBALISATION/TARGET SHIFTING increase in the

  25. Slide 25: Strategic intentions SBA Care

    Strategic intentions SBA Care 01. CONSOLIDATION OF THE COMPETITIVE POSITIONING consolidate the market share on the H-PUB target on a national level and the DEVELOPMENT DRIVERS current territorial presence (approx. 50% of the domestic market) through: - continuous participation in important tenders,

  26. Slide 26: Strategic intentions Other SBAs

    Strategic intentions Other SBAs DEVELOPMENT DRIVERS AUTOMATION AUTOMATION PRODUCT AND VALUE PROPOSITION INNOVATION THROUGH R&D OPERATIONS develop new technological • Italy retail (H-PRI, NH-PRI) solutions (e.g. automated basket/cabinet system for medical devices/cart kit engineering, etc.) and enter

  27. Slide 27: 2024 economic-financial targets

    2024 economic-financial targets Equal scope of consolidation as of 31/12/2019 2019 2024 REVENUE CAGR 2019-2024 > 4% 241.0 > 295.0 13.5% >15.0% EBITDA 82.8 ≤ 1xEBITDA NFP Million Euros 27

  28. Slide 28: 2024 Revenue and EBITDA without M&As

    2024 Revenue and EBITDA without M&As ASA breakdown, equal scope of consolidation as of 31/12/2019 Revenue by strategic business area EBITDA by strategic business area 28

  29. Slide 29: M&A Guidelines

    M&A Guidelines

  30. Slide 30: Historic M&A process

    1988 Pt established in October e Historic M&A process ACQUIRED Spid (16%) Selfin (health) INCREASED HOLDING IN Sysline (70%) ESTABLISHED CRG MADO ACQUIRED & CONSOLIDATED Logicast (100%) Larea (100%) Argentea (100%) ACQUIRED Sysline(65%) ESTABLISHED Selfin.it 30 ACQUIRED Sintac (23%) CONSOLIDATED Sel

  31. Slide 31: M&A Guidelines

    M&A Guidelines ITALY EXPORT 1. Product portfolio evolution 1. Structured software software/services/territories TARGET companies (€20-30 M (€1-10 M revenues) revenues) 2. Big players 2. Product portfolio evolution 31

  32. Slide 32: M&A Guidelines: Resources

    M&A Guidelines RESOURCES • BONDS • TRADITIONAL FINANCING • WARRANTS • SHARES/SHARES • Big players • Abroad 32

  33. Slide 33: Investment Attractiveness

    Investment Attractiveness Leadership and Uniqueness GPI IN THE STOCK MARKET Bloomberg: GPI:IM 15,909,539 Ordinary Shares (ISIN: IT0005221517) Price: 6.68 € (3 August 2020) Growth and Visibility Capitalisation: 106.3 M€ (3 August 2020) ANALYST COVERAGE – Target price Technology and Service Intermonte

  34. Slide 34: IR Contact details

    IR Contact details Fabrizio Redavid Lorenzo Giollo Maria Antonietta Pireddu Mob. +39 335 1035499 Mob. +39 340 8223333 Via C. Cantù, 1 - 20123 Milan fabrizio.redavid@gpi.it lorenzo.giollo@gpi.it Tel. +39 02 45473883/4 m.pireddu@irtop.com Via Ragazzi del '99, 13 - 38123 Trento T +39 0461 381515 invest

  35. Slide 35: Disclaimer

    Disclaimer The material in this presentation was prepared by GPI S.p.A. ("GPI” or the “Company”) without any paragraph 2, letters a) to d) of the Order; and (C) other persons to whom this presentation can be form of independent verification; it is general, basic information about the current busines

GPI — Investor Presentation (August 2020) on 6ix